|Table of Contents|

Clinical analysis of 676 cases of cervical cancer in Xinjiang China

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2019 02
Page:
303-306
Research Field:
Publishing date:

Info

Title:
Clinical analysis of 676 cases of cervical cancer in Xinjiang China
Author(s):
Ma Yuhua; Zhang Zegao; Ma Miaomiao; Pulat Nurbek; Yang Jie; Qi Xiaoli
The Second Department of Radiotherapy,People's Hospital of Xinjiang Uygur Autonomous Region,Xinjiang Urumqi 830001,China.
Keywords:
cervical cancer; Uygur; ethnic minorities; epidemiology
PACS:
R737.33
DOI:
10.3969/j.issn.1672-4992.2019.02.031
Abstract:
Objective:To investigate the clinicopathological data of cervical cancer in Xinjiang,and to provide some evidences for effective prevention,diagnosis and management of cervical cancer.Methods:Data of 676 cases of cervical cancer patients from January 2009 to December 2012 in our hospital were retrospectively analyzed for their general information,tumour pathological types and clinical stages.Results:Among the 676 cervical cancer patients,Uygur patients accounted for the majority,552 cases(81.6%).Aged from 24 to 85 years old,with a median age of 50,most of the cases were 40~49 years and 50～59 years old,accounting for 33.3% and 30.8%,respectively.The majority of clinical pathologic type was cauliflower,accounting for 43.79%.The majority of histopathological type was squamous cell carcinoma (95.12%).Moderately and poorly differentiated cancers were most common,accounting for 38.46% and 33.88%,respectively.FIGO clinical stage Ⅲb was the most common stage,accounting for 40.5%.According to the ethnic group analysis,the proportion of advanced stage patients in Uighur was higher than in Han and other ethnic minorities,and there was no significant difference in the other pathological factors.Conclusion:Uygur women were more susceptible to cervical cancer in Xinjiang,and moderately and poorly differentiated squamous cell carcinoma were most common,accounting for 38.46% and 33.88%,respectively.The majority of patients had advanced cervical cancer,and compared with Han and other ethnic minorities,Uighurs had a relatively higher proportion of advanced stages.

References:

［1］ Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012［J］.CA Cancer J Clin,2015,65(2):87-108.
［2］ Vargas-Torres SL,Portari EA,Silva AL,et al.Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia［J］.Tumour biology,2016,37(8):10469-10478.
［3］ Cheng WQ,Zhang SW,Zeng HM,et al.Report of cancer incidence and mortality in China,2010［J］.China Cancer,2014,23(1):1-10.［陈万青,张思维,曾红梅,等.中国2010年恶性肿瘤发病与死亡［J］.中国肿瘤,2014,23(1):1-10.］
［4］ Hu SY,Zheng RS,Zhao FH,et al.Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008［J］.Acta Academiae Medicinae Sinicae,2014,36(2):119-125.［胡尚英,郑荣寿,赵方辉,等.1989至2008年中国女性子宫颈癌发病和死亡趋势分析［J］.中国医学科学院学报,2014,36(2):119-125.］
［5］Moore MA,Attasara P,Khuhaprema T,et al.Cancer epidemiology in mainland South-East Asia - past,present and future［J］.Asian Pac J Cancer Prev,2010,11(Suppl 2):67-80.
［6］ Jiang SQ,Tu SA,Zhou JL,et al.Investigation and analysis of gynecopathy in Cele county of Xinjiang,China［J］.Maternal and Child Health care of china,2006,21(4):524-525.［姜淑清,土送爱,周俊兰,等.新疆策勒县妇女病现状调查与分析［J］.中国妇幼保健,2006,21(4):524-525.］
［7］ Cheng JX,Yao LL,Li HY,et al.Clinical analysis of 5 766 cases of cervical cancer［J］.Journal of Practical Obstetrics and Gynecology,2014,30(10):768-772.［程静新,姚立丽,李贺月,等.5766例宫颈癌临床特征分析［J］.实用妇产科杂志,2014,30(10):768-772.］
［8］Li W,Wang DZ,Shen CF,et al.Incidence trends of cervical cancer in Tianjin,2007-2013［J］.Chinese Journal of Epidemiology,2016,37(5):699-701.［李威,王德征,沈成凤,等.天津市2007-2013年宫颈癌发病趋势及流行特征分析［J］.中华流行病学杂志，2016,37(5),699-701.］
［9］Tobing MD,Sahiratmadja E,Dinda M,et al.Human papillomavirus genotypes profile in cervical cancer patients at Dr.Hasan saddikin general hospital,bandung,indonesia［J］.Asian Pac J Cancer Prev,2014,15(14):5781-5785.
［10］ Ma YH,Ayiguli·Yibulayinmu,Yang J,et al.Signficance of HPV genotypes in cervical lesions［J］.Modern Oncology,2016,24(06):977-981.［马玉花,阿依古丽·依布拉音木,杨杰,等.HPV分型检测及其在宫颈病变中的意义［J］.现代肿瘤医学,2016,24(6),977-980.］
［11］ Han LL,Zhao TX,Deng XH.Preliminary analysis of the relationship between new cases of cervical cancer and screening in Beijing［J］.Chinese Journal of Reproductive Health,2015,26(1):37-39.［韩历丽,赵同香,邓小虹.北京市子宫颈癌新发病例与筛查工作关系的初步分析［J］.中国生育健康杂志,2015,26(1):37-39.］
［12］ Zhu Jun,Zhao Weidong,Li Donglin,et al.Characteristics of pelvic lymph node metastases of FIGO stages Ⅰ a2-Ⅱ a2cervical cancer［J］.Guangdong Medical Journal,2015,36(23):3619-3622.［朱俊,赵卫东,李东林,等.Ⅰ a2-Ⅱ a2期宫颈癌盆腔淋巴结转移的特点［J］.广东医学,2015,36(23):3619-3622.］
［13］ Liu HQ.Epidemiological characteristics and risk factors of cervical cancer in China［J］.Maternal and Child Health Care of China,2016,31(6):1258-1260.［刘慧强.我国宫颈癌流行病学特征和高危因素分析［J］.中国妇幼保健,2016,31(6):1258-1260.］

Memo

Memo:
医学联合基金项目(编号：2015211C211)
Last Update: 1900-01-01